CKD affects bone metabolism with a decreased level of the active form of vitamin D, namely, 1,25 dihydroxy vitamin D [1,25(OH)2D], and an increased level of the parathyroid hormone (PTH), resulting in CKD-mineral bone disease (MBD)[9]. This evidence concerns the gene PTH and Marchiafava-Bignami disease.